Imogen Elsum

1.1k total citations
17 papers, 885 citations indexed

About

Imogen Elsum is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Imogen Elsum has authored 17 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Epidemiology. Recurrent topics in Imogen Elsum's work include Hippo pathway signaling and YAP/TAZ (8 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and HIV/AIDS Research and Interventions (4 papers). Imogen Elsum is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (8 papers), Wnt/β-catenin signaling in development and cancer (6 papers) and HIV/AIDS Research and Interventions (4 papers). Imogen Elsum collaborates with scholars based in Australia, United States and United Kingdom. Imogen Elsum's co-authors include Patrick O. Humbert, Helena E. Richardson, Ryan Galea, Nicola A. Grzeschik, Lukas E. Dow, Laura L. Yates, Claire Martin, Kathryn M. Kinross, Helen Pearson and Nathan Gödde and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

In The Last Decade

Imogen Elsum

17 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imogen Elsum Australia	10	616	522	152	74	51	17	885
Hans‐Martin Herz United States	10	534 0.9×	268 0.5×	114 0.8×	131 1.8×	35 0.7×	13	699
Vasileia Sapountzi United Kingdom	9	786 1.3×	255 0.5×	273 1.8×	75 1.0×	72 1.4×	11	1.1k
Matthew W. Bunce United States	11	462 0.8×	413 0.8×	64 0.4×	100 1.4×	49 1.0×	20	989
Irmgard Hofmann Switzerland	7	509 0.8×	264 0.5×	228 1.5×	59 0.8×	32 0.6×	8	745
Wei-Chien Yuan United States	9	821 1.3×	407 0.8×	200 1.3×	104 1.4×	67 1.3×	9	1.1k
Mary Shen United States	10	578 0.9×	253 0.5×	103 0.7×	187 2.5×	76 1.5×	12	829
Laurent Henry France	16	537 0.9×	197 0.4×	155 1.0×	79 1.1×	47 0.9×	36	772
Iwo Kuciński United Kingdom	13	453 0.7×	281 0.5×	86 0.6×	210 2.8×	39 0.8×	21	804
Christi Andrin Canada	8	644 1.0×	329 0.6×	111 0.7×	138 1.9×	47 0.9×	9	838
Hanshuang Shao United States	13	371 0.6×	267 0.5×	81 0.5×	87 1.2×	68 1.3×	23	631

Countries citing papers authored by Imogen Elsum

Since Specialization

Citations

This map shows the geographic impact of Imogen Elsum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imogen Elsum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imogen Elsum more than expected).

Fields of papers citing papers by Imogen Elsum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imogen Elsum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imogen Elsum. The network helps show where Imogen Elsum may publish in the future.

Co-authorship network of co-authors of Imogen Elsum

This figure shows the co-authorship network connecting the top 25 collaborators of Imogen Elsum. A scholar is included among the top collaborators of Imogen Elsum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imogen Elsum. Imogen Elsum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

O’Keefe, Daniel, Bridget Draper, Kathleen E. Ryan, et al.. (2023). The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia. BMJ Open. 13(7). e071665–e071665. 2 indexed citations

Keane, Richard D., Simon Ruth, Anna L. Wilkinson, et al.. (2023). Quality of life among people living with HIV aged 50 years and over in Australia: Identifying opportunities to support better ageing. HIV Medicine. 24(12). 1253–1267. 4 indexed citations

O’Keefe, Daniel, Kathleen E. Ryan, Judy Gold, et al.. (2022). Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study). BMJ Open. 12(1). e057618–e057618. 1 indexed citations

Palmer, Anna, Judy Gold, Imogen Elsum, et al.. (2021). A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community‐based testing campaign. Journal of Viral Hepatitis. 28(11). 1624–1634. 10 indexed citations

Elsum, Imogen, Emma Kowal, Ravi Savarirayan, et al.. (2020). A community-based co-designed genetic health service model for Aboriginal Australians. PLoS ONE. 15(10). e0239765–e0239765. 4 indexed citations

Elsum, Imogen, et al.. (2020). Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia. Journal of Viral Hepatitis. 28(3). 569–572. 10 indexed citations

Elsum, Imogen, et al.. (2019). Inclusion of Indigenous Australians in biobanks: a step to reducing inequity in health care. The Medical Journal of Australia. 211(1). 7–7. 8 indexed citations

Gödde, Nathan, Luke Pase, Imogen Elsum, et al.. (2017). The Asymmetric Cell Division Regulators Par3, Scribble and Pins/Gpsm2 Are Not Essential for Erythroid Development or Enucleation. PLoS ONE. 12(1). e0170295–e0170295. 5 indexed citations

Lavu, Evelyn, Jessica Markby, Eman Aleksic, et al.. (2017). High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea. PLoS ONE. 12(2). e0170265–e0170265. 8 indexed citations

10.

Elsum, Imogen, Laura L. Yates, Helen Pearson, et al.. (2013). Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Oncogene. 33(48). 5523–5533. 46 indexed citations

11.

Elsum, Imogen & Patrick O. Humbert. (2013). Localization, Not Important in All Tumor-Suppressing Properties: A Lesson Learnt from Scribble. Cells Tissues Organs. 198(1). 1–11. 19 indexed citations

12.

Elsum, Imogen, Claire Martin, & Patrick O. Humbert. (2013). Scribble regulates an EMT–polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. Journal of Cell Science. 126(Pt 17). 3990–9. 73 indexed citations

13.

Elsum, Imogen, Laura L. Yates, Patrick O. Humbert, & Helena E. Richardson. (2012). The Scribble–Dlg–Lgl polarity module in development and cancer: from flies to man. Essays in Biochemistry. 53. 141–168. 100 indexed citations

14.

Pearson, Helen, Pedro A. Pérez–Mancera, Lukas E. Dow, et al.. (2011). SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. Journal of Clinical Investigation. 121(11). 4257–4267. 143 indexed citations

15.

Gödde, Nathan, Ryan Galea, Imogen Elsum, & Patrick O. Humbert. (2010). Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions. Journal of Mammary Gland Biology and Neoplasia. 15(2). 149–168. 68 indexed citations

16.

Humbert, Patrick O., et al.. (2008). Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene. 27(55). 6888–6907. 254 indexed citations

17.

Dow, Lukas E., et al.. (2008). Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene. 27(46). 5988–6001. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact